CalciMedica, Inc. (CALC )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol CALC
- Company CalciMedica, Inc.
- Price $0.63
- Changes Percentage -6.58
- Change -0.04
- Day Low $0.6
- Day High $0.67
- Year High $7.2
- Year Low $0.59
- Market Cap $9,018,863
- Price Avg 50 EMA (D) $4.77
- Price Avg 200 EMA (D) $3.1
- Exchange NASDAQ
- Volume 844,619
- Average Volume 996,521
- Open $0.65
- Previous Close $0.67
- EPS -1.62
- PE -0.39
- Earnings Announcement 2026-03-26 12:00:00
- Shares Outstanding $14,409,431
Company brief: CALCIMEDICA, INC. (CALC )
- Healthcare
- Biotechnology
- Dr. A. Rachel Leheny Ph.D.
- https://www.calcimedica.com
- US
- N/A
- 06-14-2023
- US38942Q2021
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.